Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies

Clinical trial NCT00595686 · COMPLETED

Trial details

NCT number: NCT00595686
Sponsor: Esanex Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Neoplasms

Start date: 2008-01-01
Primary completion: 2010-05-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.